Objective: This study was conducted to culturally adapt the Epilepsy-Related Apathy Scale in Adults with Epilepsy (E-RAS) to Turkish and to assess its psychometric properties in adult epilepsy patients.
Methods: A total of 172 epilepsy patients receiving care at the Neurology clinic and outpatient clinic of Fırat University Hospital from February to July 2023 were included in this methodological investigation. The E-RAS was translated into Turkish, and its content and construct validity were thoroughly examined. Construct validity was assessed through exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). Reliability was evaluated through item analyses, internal consistency analysis, composite reliability coefficient, and mean explained variance analysis.
Results: The factor loadings of the scale items ranged from 0.66 to 0.89. The fit index values of the scale were X = 467.09, df = 245 (p <0.05), X/df = 1.9, RMSEA = 0.073, CFI = 0.97, RMR = 0.046, SRMR = 0.057, TLI = 0.97, and AIC = 557.09. The Cronbach's alpha coefficients of the sub-dimensions of the scale ranged from 0.880 to 0.992, and the total Cronbach's alpha coefficient was 0.928. The total McDonald's omega coefficient was 0.916, and the McDonald's omega coefficients of the sub-dimensions ranged from 0.880 to 0.947. The Turkish form of the 24-item and 4-sub-dimensional scale was validated without any changes to the original scale form.
Significance: The Turkish adaptation of E-RAS is a valid and reliable instrument for measuring apathy in adult epilepsy patients. Its use in clinical practice is strongly recommended.
Plain Language Summary: The E-RAS scale can be used to assess apathy in adults with epilepsy. The was determined that the adapted Turkish form had a similar structure to the original scale. It was determined that the E-RAS scale is valid and reliable in Turkish culture. The fact that the Turkish adaptation of the scale is similar to the original structure and other adapted cultures is a factor that facilitates its use and acceptance in international comparisons. The scale can be used to assess apathy in adults with epilepsy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/epi4.13094 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Manifestations.
Alzheimers Dement
December 2024
Harvard University School of Medicine, Cambridge, MA, USA.
Background: Exposure to repetitive head impacts (RHI) is associated with the neurodegenerative tauopathy chronic traumatic encephalopathy (CTE). There is substantial heterogeneity in the clinical presentation of CTE. Younger age of first exposure (AFE) to American football has not been associated with odds or severity of CTE.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
Brunel University London, London, United Kingdom.
Background: Mild Behavioral Impairment (MBI) describes a spectrum of late-life onset, sustained neuropsychiatric symptoms grouped in five domains: mood/anxiety, apathy, impulse dyscontrol, social inappropriateness and psychosis. MBI is a well-established correlated of incident dementia and is associated with PET amyloid and blood biomarker profiles consistent with early AD however little is known about the trajectory of MBI. This study set out to determine the course of MBI symptoms in a cohort of older adults with and without subjective cognitive complaints (SCC).
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
Harvard Medical School, Boston, MA, USA; Brigham and Women's Hospital/Massachusetts General Hospital, Boston, MA, USA.
Background: Apathy is a common neuropsychiatric symptom of Alzheimer's disease (AD) and has been linked to greater levels of AD biomarkers (i.e., global cortical amyloid burden and regional tau levels) in preclinical individuals.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
University of Strathclyde, Glasgow, United Kingdom.
Background: Psychotic symptoms (delusions and/or hallucinations) are among the most common and impactful neuropsychiatric symptoms that occur within Alzheimer's disease (AD): present in around half of AD patients, they are associated with increased distress for the individual and their families, poorer disease outcome, and greater risk of hospitalization and death. Using Random Forest analyses, aim of this study is to provide clarity on the value of neuroanatomical, neuropsychological, and neuropsychiatric features when predicting the presence of psychotic symptoms in AD.
Method: Data used in preparation for this study was obtained from the Alzheimer's Disease Neuroimaging Initiative database (adni.
Clinical Manifestations.
Alzheimers Dement
December 2024
University of California, Irvine, Irvine, CA, USA.
Background: Adults with Down syndrome (DS) have increased risk for developing Alzheimer's disease (AD). Several studies have found that the onset of new neuropsychiatric and behavioral symptoms in DS is associated with AD progression. There is evidence in the neurotypical population that AD-related apathy is more severe among males, while females display higher prevalence of depression, psychosis, and delusions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!